A secondary transcriptomic analysis of the landmark CALERIE randomized controlled trial — a 2-year caloric restriction study in healthy, non-obese adults — identified 151 genes significantly associated with maintaining knee extensor strength independent of overall body mass loss. Among the most notable were HSP90AA1, a heat-shock protein involved in proteostasis and muscle repair, and EIF3A, a translation initiation factor critical for protein synthesis. Pathway enrichment pointed to cellular proliferation, immune regulation, and protein secretion as key biological mechanisms underpinning strength preservation. The subset analyzed for transcriptomics comprised just 42 individuals, a meaningful limitation.
This finding addresses one of the most clinically consequential trade-offs in weight management: lean mass and functional strength loss accompanying caloric deficit. For the growing population using GLP-1 receptor agonists or structured dietary restriction to lose weight, preserving muscle is not cosmetic — it is directly tied to metabolic health, fall risk, and long-term independence. The identification of HSP90AA1 and EIF3A as candidate molecular markers is intriguing because both are theoretically modifiable through resistance training and dietary protein intake, pointing toward mechanistic overlap worth exploiting. However, this is an observational secondary analysis on a small subset, generating hypotheses rather than causal proof. Whether targeting these pathways through exercise or nutrition can meaningfully shift gene expression and protect strength during weight loss remains to be tested in adequately powered prospective trials. Incremental but directionally important for precision weight-loss strategies.